cagrilintide fda 5mg Cagrilintide 10mg Dosage & Titration

What Is Tirzepatide

Tirzepatide is a first-in-class dual incretin receptor agonist a single molecule that activates both the GIP (glucose-dependent insulinotropic polypeptide) and the GLP-1 (glucagon-like peptide-1) receptors, which is why it is often nicknamed a twincretin. [7] By engaging two incretin pathways it enhances glucose-dependent insulin secretion, promotes satiety, and delays gastric emptying, producing large effects on both glycemic control and bodyweight

Both reduce appetite and slow gastric emptying, but through different receptor systems

Any dosing figures below describe clinical-trial protocols or, for cagrilintide, research conventions with no approved label not a personal protocol